Gene Therapy
Overview
Gene Therapy is a peer-reviewed scientific journal that focuses on the latest advancements in the field of gene therapy. It publishes original research articles, reviews, and commentaries, covering topics such as gene delivery systems, gene editing technologies, and clinical applications of gene therapy. With a multidisciplinary approach, the journal serves as a valuable resource for researchers, clinicians, and students interested in understanding and harnessing the potential of gene therapy for treating genetic disorders and other diseases.
Details
Details
Abbr.
Gene Ther
Start
1994
End
Continuing
Frequency
Monthly, 2009-
p-ISSN
0969-7128
e-ISSN
1476-5462
Country
United Kingdom
Language
English
Metrics
Metrics
h-index / Ranks: 1016
174
SJR / Ranks: 1619
1671
CiteScore / Ranks: 1970
8.60
JIF / Ranks: 1521
5.1
Recent Articles
11.
Bouquet L, Bole-Richard E, Warda W, Neto Da Rocha M, Trad R, Nicod C, et al.
Gene Ther
. 2024 Dec;
PMID: 39702794
No abstract available.
12.
Schroder L, Huttermann L, Kliesow Remes A, Voran J, Hille S, Sommer W, et al.
Gene Ther
. 2024 Dec;
PMID: 39695327
Targeted gene delivery to vascular smooth muscle cells (VSMCs) could prevent or improve a variety of diseases affecting the vasculature and particularly the aorta. Thus, we aimed to develop a...
13.
Hunter J, Vite C, Molony C, ODonnell P, Wolfe J
Gene Ther
. 2024 Dec;
PMID: 39653737
Widespread distribution of transduced brain cells following delivery of AAV vectors into the cerebrospinal fluid (CSF) of the cisterna magna (CM) has been demonstrated in large animal brains. In humans,...
14.
Salimullah T, Kazazoglu Taylor B, Zerbato M
Gene Ther
. 2024 Dec;
PMID: 39643708
No abstract available.
15.
Davenport B, Wilson R, Williams A, Jones H
Gene Ther
. 2024 Dec;
PMID: 39627510
Fetal growth restriction (FGR) caused by placental insufficiency is a major contributor to neonatal morbidity and mortality. There is currently no in utero treatment for placental insufficiency or FGR. The...
16.
Zhou Y, Sach T, Ong J, Lim T, Berecz Z, Deniston C, et al.
Gene Ther
. 2024 Nov;
PMID: 39613903
Recombinant adeno-associated viral (AAV) vectors have emerged as prominent gene delivery vehicles for gene therapy. In the journey of an AAV vector, AAV vectors can be exposed to different proteolytic...
17.
Murray J, Harrison P, Scholefield J
Gene Ther
. 2024 Nov;
PMID: 39609594
We are often confronted with a simple question, "which gene editing technique is the best?"; the simple answer is "there isn't one". In 2021, a year after prime editing first...
18.
Chongmelaxme B, Yodsurang V, Vichayachaipat P, Srimatimanon T, Sanmaneechai O
Gene Ther
. 2024 Nov;
PMID: 39604484
Despite numerous studies identifying the advantages of therapies for spinal muscular atrophy (SMA), healthcare professionals encounter obstacles in determining the most effective treatment. This study aimed to investigate the effects...
19.
Snuggs J, Senter R, Whitt J, Jackson J, Le Maitre C
Gene Ther
. 2024 Nov;
PMID: 39572769
Low back pain is the leading cause of global disability with intervertebral disc (IVD) degeneration a major cause. However, no current treatments target the underlying pathophysiological causes. PCRX-201 presents a...
20.
Bloom K, Ely A, Maepa M, Arbuthnot P
Gene Ther
. 2024 Nov;
32(1):4-7.
PMID: 39558149
No abstract available.